SANUWAVE Health, Inc. Accounts Receivable, Allowance for Credit Loss, Recovery
SANUWAVE Health, Inc. (SNWV) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-03-26
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, recovery for fiscal 2024 was $2.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 |
| 2024-12-31 | $2.00K 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |